NCT05636267 Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients Status TERMINATED Phase PHASE1/PHASE2
NCT05559554 A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects Status COMPLETED Phase PHASE1
NCT05559541 Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05509361 Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis Status COMPLETED Phase PHASE3
NCT05505825 A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT05504317 A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT05489289 A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection Status RECRUITING Phase PHASE3
NCT05467995 A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis Status COMPLETED Phase PHASE2
NCT05432492 A Study of AK112 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE2
NCT05393063 A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT05382442 A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05319431 A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05260411 A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia Status COMPLETED Phase PHASE3
NCT05256472 A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05255458 A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia Status COMPLETED Phase PHASE3
NCT05255094 A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia Status COMPLETED Phase PHASE3
NCT05247684 AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05244642 A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma Status RECRUITING Phase PHASE3